Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "GE"

9918 News Found

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital
interviews | May 04, 2026

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows


Moderna posts Q1 2026 loss despite revenue surge
News | May 04, 2026

Moderna posts Q1 2026 loss despite revenue surge

Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets


OneSource Specialty Pharma's partners get Health Canada approval for generic Semaglutide injection
News | May 04, 2026

OneSource Specialty Pharma's partners get Health Canada approval for generic Semaglutide injection

Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing


Aster DM Healthcare surges in Q4
News | May 02, 2026

Aster DM Healthcare surges in Q4

Merger momentum builds as profits jump


Aakash Healthcare publishes landmark study on integrated emergency clinical codes
Hospitals | May 01, 2026

Aakash Healthcare publishes landmark study on integrated emergency clinical codes

Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals


Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection
Drug Approval | May 01, 2026

Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection

Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada


Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Biopharma | May 01, 2026

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Strong CDMO growth, improved product mix and operational leverage drive profitability expansion


Nitin Wadhwa joins Sebia as General Manager to lead India growth
People | May 01, 2026

Nitin Wadhwa joins Sebia as General Manager to lead India growth

Wadhwa brings over two decades of experience driving growth, transformation, and customer-centric strategies in the medical devices and diagnostics sector


Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
People | May 01, 2026

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion


Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine